Johnson & Johnson
- SEC CIK
- 0000200406
- Latest filing
- Aug 6, 2026
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Nov 13, 2024. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 20
- 0 vs. Q2 2024
- Portfolio value
- $427.3M
- +$26.7M (+6.7%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PTGXProtagonist Therapeutics, Inc | COM | 2,449,183 | $110.2M | 25.8% | 00.0% | Unchanged | History |
| RAPPRapport Therapeutics, Inc. | COM | 2,498,051 | $51.2M | 12.0% | 00.0% | Unchanged | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 814,586 | $39.7M | 9.3% | 00.0% | Unchanged | History |
| CTNMContineum Therapeutics, Inc. | CL A | 1,979,173 | $37.9M | 8.9% | 00.0% | Unchanged | History |
| CVRXCVRx, Inc. | COM | 4,103,430 | $36.2M | 8.5% | 00.0% | Unchanged | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 5,623,816 | $32.3M | 7.6% | 00.0% | Unchanged | History |
| PRCTPROCEPT BioRobotics Corp | COM | 357,939 | $28.7M | 6.7% | 00.0% | Unchanged | History |
| MGTXMeiraGTx Holdings plc | COM | 6,641,064 | $27.7M | 6.5% | 00.0% | Unchanged | History |
| NMRANeumora Therapeutics, Inc. | COM | 1,849,445 | $24.4M | 5.7% | 00.0% | Unchanged | History |
| XNCRXencor Inc | COM | 748,062 | $15.0M | 3.5% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 3,379,064 | $11.8M | 2.8% | 00.0% | Unchanged | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 247,598 | $4.80M | 1.1% | 00.0% | Unchanged | History |
| RLYBRallybio Corp | COM | 3,636,363 | $4.25M | 1.0% | 00.0% | Unchanged | History |
| NNOXNano-X Imaging Ltd. | ORD SHS | 158,852 | $965.8K | 0.2% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM | 1,074,658 | $752.3K | 0.2% | 00.0% | Unchanged | History |
| LABStandard Biotools Inc. | COM | 311,967 | $602.1K | 0.1% | 00.0% | Unchanged | History |
| ACETAdicet Bio, Inc. | COM | 364,472 | $524.8K | 0.1% | 00.0% | Unchanged | History |
| HLSQTessera Defense & Homeland Security Inc. | COM | 192,321 | $196.2K | <0.1% | 00.0% | UnchangedConverted for a 1-for-10 split | History |
| CLSDClearside Biomedical, Inc. | COM | 82,481 | $104.8K | <0.1% | +82,481 | New | History |
| SENSSenseonics Holdings, Inc. | COM | 54,621 | $19.1K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q2 2024 (1)
Positions held at the end of Q2 2024 that are gone from this filing.